How do I develop a process to effectively treat parturients with iron deficiency anemia?
- PMID: 32659040
- DOI: 10.1111/trf.15930
How do I develop a process to effectively treat parturients with iron deficiency anemia?
Abstract
Anemia is common in pregnant women and is associated with increased morbidity for the mother and the fetus, including increased risk of allogeneic blood transfusion. Iron deficiency is the most common etiology for anemia during pregnancy. Oral iron therapy remains the standard treatment but is often poorly tolerated due to its gastrointestinal side effects. Intravenous iron has been shown to be a safe and effective way to treat iron deficiency anemia but may be challenging to do in the outpatient setting given the need for an indwelling venous catheter and a small risk of infusion reactions. To improve outcomes associated with anemia, we launched a program to refer and treat obstetric patients with iron deficiency anemia for outpatient intravenous iron therapy through our preoperative anemia clinic. Here, we describe the process and successes of our program, including the clinical outcomes (change in hemoglobin and transfusion rates) from the first 2 years of the program.
© 2020 AABB.
References
REFERENCES
-
- World Health Organization. Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women. WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World Health Organization, 2012.
-
- Mahmood T, Rehman AU, Tserenpil G, et al. The association between iron-deficiency anemia and adverse pregnancy outcomes: a retrospective report from Pakistan. Cureus. 2019;11:e5854.
-
- Scholl TO. Maternal iron status: relation to fetal growth, length of gestation, and iron endowment of the neonate. Nutr Rev. 2011;69(suppl 1):S23-S29.
-
- Drukker L, Hants Y, Farkash R, Ruchlemer R, Samueloff A, Grisaru-Granovsky S. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for cesarean section and adverse maternal and neonatal outcomes. Transfusion. 2015;55:2799-2806.
-
- Williamson LM, Lowe S, Love EM, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999;319:16-19.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
